US Patent Issued to ENALARE THERAPEUTICS on Sept. 1 for "Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof" (Arizona, Florida Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,850, issued on Sept. 1, was assigned to ENALARE THERAPEUTICS INC..

"Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof" was invented by Robert B. Raffa (Tuscon, Ariz.) and Joseph V. Pergolizzi (Naples, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of treating a disease or condition modulated by large-conductance potassium channels, the methods including administering, to a patient in need thereof, an effective amount of a large-conductance potassium channel modulating compound. Exemplary disease or conditions that may be treated include...